MEDS (DataMEDS AI) Buyback Yield %: -92.53 (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DataMEDS AI Buyback Yield %?

DataMEDS AI MEDS -3.35% Buyback Yield % is -92.53 as of Jul. 26, 2026. The stock has 6 warning signs investors should review. Among 39 Medical Distribution companies, DataMEDS AI ranks worse than 100% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

DataMEDS AI's current buyback yield was -92.53%.

DataMEDS AI Buyback Yield % Historical Data

* Premium members only.

The historical data trend for DataMEDS AI's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DataMEDS AI Buyback Yield % Chart

DataMEDS AI Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 -28.10

DataMEDS AI Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.51 -7.47 -14.33 -28.10 -64.06

MEDS vs HEWA, BLMH, PMHS: Buyback Yield % Comparison

For the Medical Distribution subindustry, DataMEDS AI's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DataMEDS AI Buyback Yield % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, DataMEDS AI's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where DataMEDS AI's Buyback Yield % falls into.


DataMEDS AI Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

DataMEDS AI's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 11.373) / 40.46935
=-28.10%

DataMEDS AI's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 7.373) / 11.51016
=-64.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -92.53 mean?
DataMEDS AI (MEDS) has a Buyback Yield % of -92.53 as of Jul. 26, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on DataMEDS AI and its competitors. According to the industry distribution chart, DataMEDS AI ranks #39 out of 39 companies in the Medical Distribution industry.
Is DataMEDS AI's Buyback Yield % too high?
DataMEDS AI's current Buyback Yield % is -92.53. Based on the distribution chart, DataMEDS AI ranks #39 out of 39 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers.
How does DataMEDS AI's Buyback Yield % compare to HEWA and BLMH?
According to the Medical Distribution industry distribution chart, DataMEDS AI ranks #39 out of 39 companies for Buyback Yield %. This places DataMEDS AI in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
A good Buyback Yield % depends on the Medical Distribution industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on DataMEDS AI and its competitors. DataMEDS AI's current Buyback Yield % is -92.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Buyback Yield % of -92.53. The current Buyback Yield % is -92.53. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Buyback Yield % is -92.53 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DataMEDS AI Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.